Given their efficacy and acceptable safety in adults, GLP-1 RAs became logical candidates for trials in adolescents with obesity, a group with few other medication options
they help recalibrate it, teaching your body to mount an appropriate response and then shut it off when the job is done
In a randomized controlled trial conducted in 2022, participants in the Wegovy group experienced substantial weight loss, with a 15.8% reduction in body weight
These came with risks, including inconsistent or inaccurate amounts of the active ingredients
Though Sunrise Health Foods hasnt necessarily gained customers because of the GLP-1 craze, certainly, our current customers have questions about Ozempic and other GLP-1 drugs, he says
The triple agonist mechanism may offer unique advantages for diabetes management